This page includes the latest FDA filings for Travere Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Travere Therapeutics, Inc., Catalent CTS, LLC | Prescription Medication | 2024-09-10 |
Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S | Prescription Medication | 2023-04-04 |
Travere Therapeutics, Inc., Catalent CTS, LLC | Prescription Medication | 2023-02-25 |
Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S | Prescription Medication | 2022-11-18 |
Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S | Prescription Medication | 2021-11-30 |
Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S | Prescription Medication | 2020-12-15 |
Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S | Prescription Medication | 2020-06-12 |
Manchester Pharmaceuticals, LLC, Travere Therapeutics, Inc, Patheon France S.A.S | Prescription Medication | 2019-07-13 |